Antireflux stents for palliation of malignant esophagocardial stenosis

Diseases of the Esophagus

Volumn 20, Issue 2, 2007, Pages 89-93

  Schoppmeyer, K ^a   Golsong, J ^a   Schiefke, I ^a   Mossner J ^a   Caca, Karel ^b  

^a UNIVERSITY OF LEIPZIG   (Germany)

^b KLINIKUM LUDWIGSBURG   (Germany)

Author keywords

Antireflux stent; Complication; Esophagocardial stenosis; Palliation

Indexed keywords

ANTINEOPLASTIC AGENT; NARCOTIC ANALGESIC AGENT; PROTON PUMP INHIBITOR;

ADULT; ADVANCED CANCER; AGED; ANTIREFLUX OPERATION; ARGON PLASMA COAGULATION; ARTICLE; BACTERIAL PNEUMONIA; CANCER PALLIATIVE THERAPY; CANCER SURVIVAL; CARDIA CARCINOMA; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DYSPHAGIA; ENDOSCOPIC SURGERY; ESOPHAGEAL ADENOCARCINOMA; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; ESOPHAGOBRONCHIAL FISTULA; ESOPHAGUS CANCER; ESOPHAGUS STENOSIS; FEASIBILITY STUDY; FEMALE; FOLLOW UP; GASTROESOPHAGEAL REFLUX; GASTROSTOMY; HUMAN; INTERVIEW; JEJUNOSTOMY; LOWER ESOPHAGUS SPHINCTER; MALE; POSTOPERATIVE PERIOD; PREOPERATIVE PERIOD; PRIORITY JOURNAL; QUESTIONNAIRE; SAFETY; STENT; SURVIVAL RATE; THORAX PAIN;

ADENOCARCINOMA; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; DEGLUTITION DISORDERS; ESOPHAGEAL NEOPLASMS; ESOPHAGEAL STENOSIS; ESOPHAGOGASTRIC JUNCTION; FEMALE; FOREIGN-BODY MIGRATION; GASTROESOPHAGEAL REFLUX; HUMANS; MALE; MIDDLE AGED; PALLIATIVE CARE; POLYTETRAFLUOROETHYLENE; PROSTHESIS DESIGN; REOPERATION; SEVERITY OF ILLNESS INDEX; STENTS;

EID: 34147164992     PISSN: 11208694     EISSN: 14422050     Source Type: Journal    
DOI: 10.1111/j.1442-2050.2007.00646.x     Document Type: Article

References (19)

1. Devesa SS, Blot WJ, Fraumeni JF. Changing patterns in the incidence of oesophageal and gastric carcinoma in the United States. Cancer 1998; 83: 2049-53.
2. Daly JM, Fry WA, Little AG et al. Esophageal cancer: Results of an American College of Surgeons Patient Care Evaluation Study. Am Coll Surg 2000; 190: 562-72.
3. Knyrim K, Wagner HJ, Bethge N et al. A controlled trial of an expansile metal stent for palliation of esophageal obstruction due to inoperable cancer. N Engl J Med 1993; 329: 1302-7.
4. Siersema PD, Hop WC, van Blankenstein M et al. Coated self-expanding metal stent versus latex prostheses for esophagogastric cancer with special reference to prior radiation and chemotherapy: A controlled, prospective study. Gastrointest Endosc 1998; 47: 113-20.
5. Spinelli P, Cerrai FG, Ciuffi M et al. Endoscopic stent placement for cancer of the lower esophagus and gastric cardia. Gastrointest Endosc 1994; 40: 455-7.
6. Bartelsman JF, Bruno MJ, Jensema AJ et al. Palliation of patients with esophagogastric neoplasms by insertion of a covered expandable modified Gianturco-Z endoprostheis: Experience in 153 patients. Gastrointest Endosc 2000; 51: 134-8.
7. Dua KS, Kozarek R, Kim J et al. Self-expanding metal esophageal stent with anti-reflux mechanism. Gastrointest Endosc 2001; 53: 603-13.
8. Osugi H, Lee S, Higashino M et al. Usefulness of self-expandable metallic stent with an antireflux mechanism as a palliation for malignant strictures at the gastroesophageal junction. Surg Endosc 2002; 16: 1478-82.
9. Laasch HU, Marriott A, Wilbraham L, Tunnah S, England RE, Martin DF. Effectiveness of open versus antireflux stents for palliation of distal esophageal carcinoma and prevention of symptomatic gastroesophageal reflux. Radiology 2002; 225: 359-65.
10. Ogilvie AL, Dronfield MW, Ferguson A, Atkinson M. Palliative intubation of oesophagogastric neoplasms at fibre-optic endoscopy. Gut 1982; 23: 1060-7.
11. Siersema PD, Marcon N, Vakil N. Metal stents for tumor of the distal esophagus and gastric cardia. Endoscopy 2003; 35: 79-85.
12. Homs MY, Wahab PJ, Kuipers EJ et al. Esophageal stents with antireflux valve for tumors of the distal esophagus and gastric cardia: A randomized trial. Gastrointest Endosc 2004; 60: 695-702.
13. Shim CS, Jung IS, Cheon YK et al. Management of malignant stricture of the esophagogastric junction with a newly designed self-expanding metal stent with an antireflux mechanism. Endoscopy 2005; 37: 335-9.
14. Steyerberg EW, Homs MY, Stokvis A, Essink-Bot ML, Siersema PD. Stent placement or brachytherapy for palliation of dysphagia from esophageal cancer: A prognostic model to guide treatment selection. Gastrointest Endosc 2005; 62: 333-40.
15. Homs MYV, Steyerberg EW, Eijkenboom WMH et al. Single-dose brachytherapy versus metal stent placement for the palliation of dysphagia from oesophageal cancer: Multicentre randomised trial. Lancet 2004; 364: 1497-504.
16. Bergquist H, Wenger U, Johnsson E et al. Stent insertion or endoluminal brachytherapy as palliation of patients with advanced cancer of the esophagus and gastroesophageal junction. Results of a randomized, controlled clinical trial. Dis Esophagus 2005; 18: 131-9.
17. Homs MY, Steyerberg EW, Eijkenboom WM, Siersema PD. Predictors of outcome of single-dose brachytherapy for the palliation of dysphagia from esophageal cancer. Brachytherapy 2006; 5: 41-8.
18. Wenger U, Johnsson E, Bergquist H et al. Health economic evaluation of stent or endoluminal brachytherapy as a palliative strategy in patients with incurable cancer of the oesophagus or gastro-oesophageal junction: results of a randomized clinical trial. Eur J Gastroenterol Hepatol 2005; 17: 1369-77.
19. Polinder S, Homs MY, Siersema PD, Steyerberg EW. Cost study of metal stent placement vs single-dose brachytherapy in the palliative treatment of oesophageal cancer. Br J Cancer 2004; 90: 2067-72.